Package 61703-303-46

Brand: cytarabine

Generic: cytarabine
NDC Package

Package Facts

Identity

Package NDC 61703-303-46
Digits Only 6170330346
Product NDC 61703-303
Product ID 61703-303_304df26a-131c-4ce1-999a-f13ade44373e
Description

1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (61703-303-46) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE

Marketing

Marketing Status
Marketed Since 1990-08-31
Brand cytarabine
Generic cytarabine
Sample Package No

Linked Drug Pages (1)

CYTARABINE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "304df26a-131c-4ce1-999a-f13ade44373e", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["04079A1RDZ"], "rxcui": ["240416"], "spl_set_id": ["681b5dc4-4fcf-4fab-ad78-02cb9a4a5dd0"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Hospira, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (61703-303-46)  / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE", "package_ndc": "61703-303-46", "marketing_start_date": "19900831"}], "brand_name": "CYTARABINE", "product_id": "61703-303_304df26a-131c-4ce1-999a-f13ade44373e", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "61703-303", "generic_name": "CYTARABINE", "labeler_name": "Hospira, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CYTARABINE", "active_ingredients": [{"name": "CYTARABINE", "strength": "20 mg/mL"}], "application_number": "ANDA072168", "marketing_category": "ANDA", "marketing_start_date": "19900831", "listing_expiration_date": "20261231"}